![]() |
產(chǎn)地 | 進(jìn)口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS10465 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-PAX6 |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human PAX6(54-103 aa) |
中文名稱 轉(zhuǎn)錄因子Pax6抗體費(fèi)用
英文名稱 Anti-PAX6
別 名 AN 2; AN antibody; AN2; Aniridia type II protein; D11S812E; MGC17209; MGDA; Oculorhombin; Paired box 6; Paired box gene 6 (aniridia keratitis); Paired Box Gene 6; Paired box homeotic gene 6; Paired box protein Pax-6; Paired box protein Pax6; PAX 6; PAX6; PAX6_HUMAN; Sey; WAGR.
產(chǎn)品屬性:
轉(zhuǎn)錄因子Pax6抗體費(fèi)用 濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 發(fā)育生物學(xué) 神經(jīng)生物學(xué) 干細(xì)胞
蛋白分子量 predicted molecular weight: 46kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PAX6(54-103 aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
轉(zhuǎn)錄因子Pax6抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Pax genes contain paired domains with strong homology to genes in Drosophila which are involved in programming early development. The PAX2 gene is expressed in primitive cells of the kidney, ureter, eye, ear, and central nervous system. More specifically, in human embryo sections, PAX2 is expressed in the optic vesicle and later in the retina, in the otic vesicle and later in the semicircular canals of the inner ear, and in mesonephros, metanephros, adrenals, spinal cord, and hindbrain. PAX2 mutations can be responsible for renal hypoplasia, either isolated or associated with various ophthalmologic manifestations ranging from retinal coloboma to microphthalmia. The gene which encodes Pax-2 maps to human chromosome 10q24.3-q25.1. Lesions in the PAX6 gene accounts for most cases of aniridia, a congenital malformation of the eye, chiefly characterized by iris hypoplasia, which can cause blindness. PAX6 is involved in other anterior segment malformations besides aniridia, such as Peters anomaly, a major error in the embryonic development of the eye with corneal clouding with variable iridolenticulocorneal adhesions. The gene which encodes Pax-6 maps to human chromosome 11p13.
Function : Transcription factor with important functions in the development of the eye, nose, central nervous system and pancreas. Required for the differentiation of pancreatic islet alpha cells (By similarity). Competes with PAX4 in binding to a common element in the glucagon, insulin and somatostatin promoters. Regulates specification of the ventral neuron subtypes by establishing the correct progenitor domains (By similarity). Isoform 5a appears to function as a molecular switch that specifies target genes.
Subunit : Interacts with MAF and MAFB (By similarity). Interacts with TRIM11; this interaction leads to ubiquitination and proteasomal degradation, as well as inhibition of transactivation, possibly in part by preventing PAX6 binding to consensus DNA sequences.
Subcellular Location : Nucleus.
Post-translational modifications : Ubiquitinated by TRIM11, leading to ubiquitination and proteasomal degradation.
DISEASE : Defects in PAX6 are the cause of aniridia (AN) [MIM:106210]. A congenital, bilateral, panocular disorder characterized by complete absence of the iris or extreme iris hypoplasia. Aniridia is not just an isolated defect in iris development but it is associated with macular and optic nerve hypoplasia, cataract, corneal changes, nystagmus. Visual acuity is generally low but is unrelated to the degree of iris hypoplasia. Glaucoma is a secondary problem causing additional visual loss over time.
Defects in PAX6 are a cause of Peters anomaly (PAN) [MIM:604229]. Peters anomaly consists of a central corneal leukoma, absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iris and lenticular attachments to the central aspect of the posterior cornea.
Defects in PAX6 are a cause of foveal hypoplasia (FOVHYP) [MIM:136520]. Foveal hypoplasia can be isolated or associated with presenile cataract. Inheritance is autosomal dominant.
Defects in PAX6 are a cause of keratitis hereditary (KERH) [MIM:148190]. An ocular disorder characterized by corneal opacification, recurrent stromal keratitis and vascularization.
Defects in PAX6 are a cause of coloboma of iris choroid and retina (COI) [MIM:120200]; also known as uveoretinal coloboma. Ocular colobomas are a set of malformations resulting from abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure). Severe colobomatous malformations may cause as much as 10% of the childhood blindness. The clinical presentation of ocular coloboma is variable. Some individuals may present with minimal defects in the anterior iris leaf without other ocular defects. More complex malformations create a combination of iris, uveoretinal and/or optic nerve defects without or with microphthalmia or even anophthalmia.
Defects in PAX6 are a cause of coloboma of optic nerve (COLON) [MIM:120430].
Defects in PAX6 are a cause of bilateral optic nerve hypoplasia (BONH) [MIM:165550]; also known as bilateral optic nerve aplasia. A congenital anomaly in which the optic disc appears abnormally small. It may be an isolated finding or part of a spectrum of anatomic and functional abnormalities that includes partial or complete agenesis of the septum pellucidum, other midline brain defects, cerebral anomalies, pituitary dysfunction, and structural abnormalities of the pituitary.
Defects in PAX6 are a cause of aniridia cerebellar ataxia and mental deficiency (ACAMD) [MIM:206700]; also known as Gillespie syndrome. A rare condition consisting of partial rudimentary iris, cerebellar impairment of the ability to perform coordinated voluntary movements, and mental retardation.
Similarity : Belongs to the paired homeobox family.
Contains 1 homeobox DNA-binding domain.
Contains 1 paired domain.
實(shí)驗(yàn)流程:
全、新、優(yōu)、品、好四大特點(diǎn):
轉(zhuǎn)錄因子Pax6抗體費(fèi)用 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★轉(zhuǎn)錄因子Pax6抗體費(fèi)用 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程:原核、哺乳動物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品:
Apo A1(Human anti-apolipoprotein A1 antibody) ELISA Kit 人抗載脂蛋白抗體A1Multi-class antibodies規(guī)格: 48T
Anti-phospho-IkB beta (Ser23) 磷酸化KB抑制蛋白β抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh MAGEB4 相關(guān)抗原B4抗體 規(guī)格 0.2ml
25(OH)D3/25 HVD3(Human 25-Dihydroxy vitamin D3)ELISA Kit 人25羥基維生素D3 96T
ROR alpha 英文名稱: 維相關(guān)孤兒受體α抗體 0.2ml
CC85C 英文名稱: 卷曲螺旋域蛋白質(zhì)85C抗體 0.2ml
Anti-phospho-IkB beta (Ser23) 磷酸化KB抑制蛋白β抗體Multi-class antibodies規(guī)格: 0.1ml
BK(Mouse bradykinin) ELISA Kit 小鼠舒緩激肽Multi-class antibodies規(guī)格: 48T
Anti-CD79A/IGBP-1 /FITC 熒光素標(biāo)記免疫球蛋白結(jié)合蛋白-1抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh DPF2/D4 zinc and double PHD fingers family 2 雙PHD-D4鋅指蛋白2抗體 規(guī)格 0.2ml
CMV 巨細(xì)胞病毒 IgG(間接法二步法)
MURF3 英文名稱: 肌肉特異性環(huán)指蛋白3抗體 0.2ml
ALAD 英文名稱: δ基乙酰脫水酶抗體 0.2ml
Anti-CD79A/IGBP-1 /FITC 熒光素標(biāo)記免疫球蛋白結(jié)合蛋白-1抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-MTLR/FITC 熒光素標(biāo)記抗胃動素受體抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-UCN/FITC 熒光素標(biāo)記新型活性因子UCN抗體(小鼠、大鼠)IgGMulti-class antibodies規(guī)格: 0.2ml
拮抗凋亡轉(zhuǎn)錄因子抗體 Anti-AATF 0.2ml
Mouse Anti-rabbit IgG/FITC FITC標(biāo)記的小鼠抗兔IgG 0.3ml
GCOM1 英文名稱: GCOM1蛋白抗體 0.2ml
Rhesus antibody Rh PSA(Pa3) 人特異性抗原單克隆抗體(包被) 規(guī)格 0.1ml
Anti-UCN/FITC 熒光素標(biāo)記新型活性因子UCN抗體(小鼠、大鼠)IgGMulti-class antibodies規(guī)格: 0.2ml
大鼠甲狀腺素(T4)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
人去乙酰化酶Siuin-2(SI2/SIR2L/SIR2L2)免疫試劑盒 Human SI2/SIR2L/SIR2L2 ELISA Kit
MouseL-SelectinELISAKit小鼠L選擇素(L-Selectin/CD62L)ELISA試劑盒規(guī)格:96T/48T
IL-8(抗人;抗兔;抗小鼠;抗大鼠)100微克
Humanneuophilpeptide1-3,HNP1-3ELISA試劑盒人中性粒細(xì)胞防御素1-3(HNP1-3)ELISA試劑盒規(guī)格:96T/48T
HumanPulmonarysurfatca-associatedproteinA,SP-AELISAKit人肺表面活性物質(zhì)相關(guān)蛋白A(SP-A)ELISA試劑盒規(guī)格:96T/48T
大鼠β-轉(zhuǎn)導(dǎo)重復(fù)相容蛋白(β-CP)ELISA試劑盒 ,英文名: β-CP ELISA Kit
Mouse esadiol (E2) ELISA Kit 小鼠雌二醇(E2)ELISA試劑盒
ELISA 小鼠基質(zhì)金屬蛋白酶-9(mouse MMP-9) 48T/96T 進(jìn)口分裝
CLIAKitforIL-16(HumanIerleukin16)ELISAKIT人白介素16規(guī)格:48T/96T
通用型硫氰酸酶(rhodanase)活性比色法定量檢測試劑盒20次
ELISAKitBK大鼠舒緩激肽規(guī)格:48T/96T
轉(zhuǎn)錄因子Pax6抗體費(fèi)用 大鼠白細(xì)胞介素6(IL-6)ELISA試劑盒 ,英文名: IL-6 ELISA Kit
Mouse macrophage inflammatory protein 1 alpha (MIP-1 alpha /CCL3) ELISA Kit 小鼠巨噬細(xì)胞炎性蛋白1α(MIP-1α/CCL3)ELISA試劑盒
MouseorphaninFQ/nociceptin,OFQ/NELISAKit 小鼠孤腓肽(OFQ/N)ELISA試劑盒 96T/48T 進(jìn)口分裝
CLIAKitforHumanorosomucoid,ORMELISAKit人類粘蛋白規(guī)格:48T/96T
同位素核酸(酶切產(chǎn)物)蛋白結(jié)合DNA酶足跡法分析試劑盒10次
ELISAKitG-CSF大鼠粒細(xì)胞集落刺激因子規(guī)格:48T/96T